Literature DB >> 10650117

MR findings in pulmonary hypertrophic osteoarthropathy.

A Capelastegui1, E Astigarraga, C García-Iturraspe.   

Abstract

Entities:  

Mesh：

Year:  2000        PMID： 10650117     DOI： 10.1053/crad.1999.0101

Source DB:  PubMed          Journal:  Clin Radiol        ISSN： 0009-9260            Impact factor:   2.350


× No keyword cloud information.
  6 in total

Review 1.  Update on imaging of non-infectious musculoskeletal complications of HIV infection.

Authors:  T C Booth; N C Chhaya; J R G Bell; B J Holloway
Journal:  Skeletal Radiol       Date:  2012-05-23       Impact factor: 2.199

Review 2.  Paraneoplastic musculoskeletal disorders: review and update for radiologists.

Authors:  Kimia Khalatbari Kani; Jack A Porrino; Michael E Mulligan; Felix S Chew
Journal:  Skeletal Radiol       Date:  2022-05-23       Impact factor: 2.199

3.  Clinical Course of Hypertrophic Pulmonary Osteoarthropathy in a Patient Receiving Immune Checkpoint Inhibitor Therapy.

Authors:  Andrew C Johns; Chad Sorenson; Alan Rogers; Julia L Agne; Desmond M D'Souza; Jishu K Das; Majd Issa; Gina Perna; Terence M Williams; Alexa Meara; Trevor Kitchin; Karl E Haglund; Dwight H Owen
Journal:  Clin Lung Cancer       Date:  2020-01-27       Impact factor: 4.785

4.  Hypertrophic pulmonary osteoarthropathy on bone scintigraphy and 18F-fluorodeoxyglucose positron emission tomography/computed tomography in a patient with lung adenocarcinoma.

Authors:  Arzu Cengiz; Mine Şencan Eren; Mehmet Polatli; Yakup Yürekli
Journal:  Indian J Nucl Med       Date:  2015 Jul-Sep

5.  Primary hypertrophic osteoarthropathy and bilateral transient lateral patellar dislocation in an adolescent.

Authors:  Sharenja Jeyabaladevan; Emmanouil Astrinakis; Margaret Callan; Paul Anthony Sookur
Journal:  BJR Case Rep       Date:  2021-12-24

6.  Secondary hypertrophic osteoarthropathy caused by non-pleural or pulmonary tumors.

Authors:  Hans-Jonas Meyer; Leonard Leifels; Andreas Gunter Bach; Alexey Surov
Journal:  Medicine (Baltimore)       Date:  2017-09       Impact factor: 1.889
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.